Metraipolis › archive › dc_de7ebe738de0

Rethinking Synthetic Berberine in Nutraceuticals: Nitrosamine Risks, Regulatory Oversight, and Safer Alternatives — Europe PMC PMID:41226233

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41226233
DOI
10.3390/molecules30214274
License (as archived)
solo-consultazione
Archived
2026-11-08T19:48:09.394Z
SHA-256 of the archived text
d7d7c73135f8a604106c712ca89a702eed43e68e4368d1f83e0c7b081818186b
Stable URL of this page
https://metraipolis.com/documento/dc_de7ebe738de0

How to cite

Rethinking Synthetic Berberine in Nutraceuticals: Nitrosamine Risks, Regulatory Oversight, and Safer Alternatives — Europe PMC PMID:41226233 — Europe PMC (en), https://europepmc.org/article/MED/41226233 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_de7ebe738de0 (Metraipolis archive dc_de7ebe738de0, sha256 d7d7c73135f8a604106c712ca89a702eed43e68e4368d1f83e0c7b081818186b)
BibTeX
@misc{dcde7ebe738de0,
  title = {Rethinking Synthetic Berberine in Nutraceuticals: Nitrosamine Risks, Regulatory Oversight, and Safer Alternatives — Europe PMC PMID:41226233},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41226233},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_de7ebe738de0; sha256 d7d7c73135f8a604106c712ca89a702eed43e68e4368d1f83e0c7b081818186b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41226233. Agents can read the archived copy with the MCP tool read_document.